Eisai: Antiepileptic Drug Fycompa Regularly Available Again in Germany from December Eisai Nov 20, 2017 14:28 HKT/SGT Read More
Hitachi Announces Pharmacotherapy Outcome Prediction Technology for Drug Selection Support in Type-2 Diabetes Mellitus Hitachi, Ltd. Nov 07, 2017 09:53 HKT/SGT Read More
RenalGuardは心臓手術に伴う急性腎障害のリスク低減に使用でき安全—初の臨床データで実証 RenalGuard Solutions, Inc. Oct 13, 2017 11:30 JST Read More
Eisai: Transfer of Rights to Anti-Rheumatic Agent Kolbet Tablets 25mg in Japan Eisai Oct 13, 2017 09:48 HKT/SGT Read More
Small and Easy to Take, Just One Tablet per Dose Eisai to Launch "Onji-No-Megumi" for Improving Forgetfulness in Middle Age and Beyond Eisai Oct 11, 2017 11:48 HKT/SGT Read More
New Silkroutes Group to Add More Clinics to Dental Portfolio to Further Expand Healthcare Business New Silkroutes Group Limited Oct 11, 2017 10:15 JST Read More
Simple Biomechanical Test could aid Implant Success Science and Technology of Advanced Materials Oct 10, 2017 23:00 JST Read More
Eisai and Biotoscana Sign Exclusive Licensing Agreement for Latin America Eisai Oct 04, 2017 09:49 HKT/SGT Read More
Nanobiotix plans to conduct its first clinical trial with NBTXR3 in combination with immune checkpoint inhibitors in the U.S. Nanobiotix Sep 29, 2017 09:00 JST Read More
メタ分析によってRenalGuard(R)が、心血管インターベンション手術を受ける患者の造影剤による急性腎不全を予防に劇的な効果のあることが明らかに RenalGuard Solutions, Inc. Sep 14, 2017 10:15 JST Read More
Eisai to Launch New "Etak Antimicrobial Spray Alpha" Containing Long-Acting Antimicrobial Agent Etak Eisai Sep 13, 2017 13:25 HKT/SGT Read More
Eisai and Mamorio to Jointly Launch "Me-Mamorio" Tracking Tool to Support People with Dementia and Seniors Going Out Eisai Sep 12, 2017 23:06 HKT/SGT Read More
Eisai Selected for Fifth Consecutive Year of Membership in Dow Jones Sustainability Asia Pacific Index 2017 Eisai Sep 12, 2017 22:37 HKT/SGT Read More
Fujitsu VR Heart Simulator Viewer to Be Utilized in University of Tokyo Lecture Fujitsu Ltd Sep 12, 2017 18:06 HKT/SGT Read More
